Navigation Links
Surgery May Not Help Most People With Narrowed Brain Artery
Date:9/25/2008

Intensive medical treatment can prevent stroke, study says

THURSDAY, Sept. 25 (HealthDay News) -- The vast majority of people at risk of stroke because the main artery to the brain is partially blocked but have no symptoms are better off if they don't have surgery to restore blood flow, a new study contends.

"Above 95 percent of patients with asymptomatic carotid stenosis can benefit if they receive intensive medical therapy rather than endarterectomy [the surgical removal of plaque from a blocked artery] or stenting," said study leader Dr. David Spence. He is director of the Stroke Prevention & Atherosclerosis Research Centre at the Robarts Research Institute at the University of Western Ontario in Canada.

A simple test can identify the small percentage of people with symptomless partial blockage of the carotid, the main artery to the brain, who are at high risk of stroke and should have the surgical procedure endarterectomy or implantation of a stent, a metal tube to maintain blood flow, Spence said.

He was expected to present the study findings Sept. 25 at the Sixth World Stroke Congress, in Vienna, Austria.

Endarterectomy for symptom-free carotid stenosis is greatly overused in the United States, Spence said. "In the United States, between half and two-thirds of these procedures are done for asymptomatic carotid stenosis," he said. "In Australia, it is between 10 and 20 percent."

Intensive medical therapy, including "exercise, the Mediterranean diet, statin doses up to the maximum regardless of LDL (bad) cholesterol level, ACE inhibitors, niacin, whatever we can do to reduce plaque," can make the risk of stroke negligible in such cases, Spence said.

"Since 2003, only 0.8 percent of patients with asymptomatic stroke have had a stroke in the first year, and zero percent have heart attacks in the first year," he added.

The year 2003 can be used as a dividing line, becaus
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Plastic Surgery 2008 to Showcase Future of Plastic Surgery Through Groundbreaking Research
2. Open cancer surgery set to become a thing of the past
3. Radiosurgery Proves Viable for Some Pancreatic Cancers
4. Weight-Loss Surgery Weighed as Diabetes Rx
5. The American Society for Laser Medicine and Surgery Holds Annual Conference on April 1-5, 2009
6. Mayo Clinic chest surgeons propose measures for indicating quality of lung surgery
7. Venous Surgery EMR: SonoSoft Chooses Practice Management Solution MPMsoft as its Medical Billing Software
8. Coastal Center for Obesity Offers Hispanics Weight Loss Surgery with a Warranty
9. Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss
10. Brain surgery is getting easier on patients
11. Gum Chewing May Speed Colon Surgery Recovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... September 01, 2015 , ... Spinal fusion surgery ... once required a long, arduous recovery. However, today’s minimally invasive fusions achieve similar ... loss and minimal muscle damage. These advantages of minimally invasive surgery redeem the ...
(Date:8/31/2015)... ... 2015 , ... Dental clinicians from Newcastle University, United Kingdom, ... learn more about its integrated approach to diabetes care. , Philip Preshaw, BDS, ... Medicine at Newcastle University, and Susan Bissett, National Institute for Health Research Clinical ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... recently opened registration for the company’s second Introduction to Hyperbaric Medicine Course. The ... 15-18, 2015 aboard the Queen Mary Hotel in Long Beach, CA. The meeting ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... Marketing and Corporate Communications. In this capacity, Michael will provide strategic leadership for ... industry leader in consumer-focused programs that have contributed to the company’s rapid growth. ...
(Date:8/31/2015)... ... 31, 2015 , ... In an article published August 24th on ... Open Journal that discusses the future of 3-D printing technology as it relates to ... implants, prosthetics, and other 3-D printed tools could be used to aid in the ...
Breaking Medicine News(10 mins):Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 3Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 4Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3
... Nov. 9 NutraCea (OTC Bulletin Board:,NTRZ), a ... stabilized rice bran,(SRB), announced today that it will ... 14 after the market closes. Management will ... 5:30 PM EST,to review NutraCea,s 2007 third quarter ...
... The medical director of the,famed Los Angeles Jewish Home ... for increased understanding of an,illness that is the 11th ... older,and expected to grow even more widespread in coming ... Alzheimer,s disease;,and unless a cure or significant treatment is ...
... Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced ... a novel, oral Syk kinase inhibitor, in patients,with ... showed that R788 (tamatinib fosdium) can improve,platelet counts ... attacks and,destroys its own blood platelets. Initiated ...
... announce their new Guideline on the Management of Nonmuscle ... are diagnosed with bladder cancer, which has been linked ... and exposure to hazardous chemicals. The AUA originally published ... is an update to that document. , The Guideline ...
... one in four men admitted to hospital with acute urinary retention ... today. , The risk of death in men after acute urinary ... broken hip. The problem is set to get worse as the ... the sudden inability to pass urine and is often a progression ...
... nation,s first Vioxx trial, hails settlement as ,the ... right thing ... Firm are,announcing a nationwide settlement agreement with pharmaceutical giant,Merck & Co. Inc. ... injury lawsuits in the U.S. over Vioxx, the company,s,controversial pain medication. ...
Cached Medicine News:Health News:NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 14 2Health News:Increased Understanding Called for During November National Alzheimer's Disease Awareness Month by Los Angeles Jewish Home's Medical Director 2Health News:Increased Understanding Called for During November National Alzheimer's Disease Awareness Month by Los Angeles Jewish Home's Medical Director 3Health News:Rigel R788 Raises Platelet Counts in Immune Thrombocytopenic Purpura (ITP) Patients in Phase 2 Study 2Health News:Rigel R788 Raises Platelet Counts in Immune Thrombocytopenic Purpura (ITP) Patients in Phase 2 Study 3Health News:Rigel R788 Raises Platelet Counts in Immune Thrombocytopenic Purpura (ITP) Patients in Phase 2 Study 4Health News:AUA releases new guidelines on non-muscle invasive bladder cancer 2Health News:Study reveals high death toll after severe urinary complications in men over 45 2Health News:The Lanier Law Firm Announces $4.85 Billion National Vioxx Settlement With Merck & Co. Inc. 2
(Date:8/31/2015)... Aug. 31, 2015  Soligenix, Inc. (OTCQB: ... company developing products that address unmet medical needs ... announced today it has completed enrollment of the ... Committee (DRC) earlier this year, into the company,s ... first-in-class innate defense regulator (IDR) and is being ...
(Date:8/31/2015)... 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... of regenerative medicine, today announced that the third ... -based Rush University Medical Center in a ... doses of AST-OPC1 (oligodendrocyte progenitor cells) in newly ... spinal cord injury (SCI). This represents the final ...
(Date:8/31/2015)... N.J. and STAMFORD, Conn. ... pharmaceutical subsidiary of Eisai Co., Ltd., and Purdue Pharma ... worldwide collaboration agreement for the development and commercialization of ... orexin receptor antagonist entering Phase III clinical development for ... terms of the agreement, Eisai and Purdue Pharma will ...
Breaking Medicine Technology:Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5
... , HELSINKI, Dec. 14 Cancer ... with the introduction of RapidArc® radiotherapy technology from Varian Medical ... radiotherapy clinic in the Nordic region. Clinicians at Docrates Clinic ... radiotherapy to treat patients with multiple brain metastases and cancers ...
... , WALTHAM, Mass., Dec. ... authority on medical technology market intelligence, increased use of safety ... be a key driver of the enteral feeding device markets ... and European Markets for Enteral Feeding Devices 2010 report ...
Cached Medicine Technology:Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3
... designed for PCR amplification and target ... systems. The NGEN product line includes ... associated with cystic fibrosis, thrombosis, and ... for the detection of sequences associated ...
... pregnancy testing, our new ICON 25 hCG ... you fast, accurate results, plus Beckman Coulter ... hCG offers CLIA waived simplicity for urine ... For the hospital, it's the perfect complement ...
AUTION ELEVEN is the eleventh model of AUTION series which is ideal for use in small-to-medium-sized hospitals and clinics with its smart design and features....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Medicine Products: